Cambria Pharmaceuticals' Series A Round

Cambria Pharmaceuticals raised a round of funding on April 15, 2008.

Cambria Pharmaceuticals is focused on discovering treatments for serious and progressively disabling neurological disorders. The company aims to exploit recent discoveries in the genetic basis of thes…

Articles about Cambria Pharmaceuticals' Series A Round: